Table 2. Comparing ER, PgR and HER-2/Neu status in the primary and metastatic tissue.
| Brain metastasis | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ER− | ER+ | PgR− | PgR+ | HER-2/Neu− | HER-2/Neu+ | ||||
| Primary | ER− | 7 | 0 | PgR− | 7 | 1 | HER-2/Neu − | 10 | 0 |
| ER+ | 3 | 4 | PgR+ | 4 | 2 | HER-2/Neu + | 0 | 6 | |
ER, estrogen receptor; PgR, progesterone receptor; HER-2+: HER-2/Neu overexpressed; HER-2−: HER-2/Neu not overexpressed